NCT00377546
Completed
Phase 4
Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
ConditionsVitrectomy
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Vitrectomy
- Sponsor
- Innovative Medical
- Locations
- 1
- Status
- Completed
- Last Updated
- 17 years ago
Overview
Brief Summary
To compare the penetration of three different NSAIDs.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Males or females scheduled to undergo Vitrectomy surgery
- •Likely to complete all study visits and able to provide informed consent
- •Visual potential of 20/25 or better
Exclusion Criteria
- •Known contraindications to any study medication or ingredients
- •Active ocular diseases or uncontrolled systemic disease
- •Active ocular allergies
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy VolunteersEye Infections, BacterialNCT00357292Laboratoires Thea
Completed
Phase 4
Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRKMyopiaHyperopiaNCT00347204Center For Excellence In Eye Care40
Completed
Phase 1
Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy VolunteersEye Infections, BacterialNCT00357539Laboratoires Thea
Unknown
Phase 4
Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)PainNCT00869219Santa Casa de Misericordia de Santos40
Withdrawn
Phase 3
Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)Age Related Macular DegenerationNCT00557791OPKO Health, Inc.